Adaptive changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine

Life Sciences

Volumn 58, Issue 9, 1996, Pages 769-776

  Fernandez, Mercedes ^a,b   Svenningsson, Per ^a   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Adenosine receptors; mRNA; R phenylisopropyl adenosine

Indexed keywords

2 CHLOROADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; GUANOSINE TRIPHOSPHATE; MESSENGER RNA; PHENYLISOPROPYLADENOSINE; RADIOLIGAND;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; RECEPTOR DOWN REGULATION;

EID: 0030054250     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(95)02355-0     Document Type: Article

References (25)

1. B.B. FREDHOLM, Acta Physiol. Scand. 115 283-286 (1982).
2. V. RAMKUMAR, J.R. BUMGARNER, K.A. JACOBSON and G.L. STILES, J. Clin. Invest. 82 242-247 (1988).
3. B. JOHANSSON, S. AHLBERG, I. VAN DER PLOEG, S BRENÉ, N LINDEFORS, H. PERSSON and B.B. FREDHOLM, Naunyn-Schmiedeberg's Arch. Pharmacol. 347 407-414 (1993).
4. R.C. SANDERS and T.F. MURRAY, Neurosci Lett. 101 325-330 (1989).
5. V. GEORGIEV, B. JOHANSSON and B.B. FREDHOLM, Brain Res 612 271-277 (1993).
6. N.M. PORTER, M. RADULOVACKI and R.D. GREEN, J. Pharmacol. Exp. Ther 244 218-225 (1988).
7. B.B. FREDHOLM, M.P. ABBRACCHIO, G. BURNSTOCK, J.W. DALY, T.K. HARDEN, K.A. JACOBSON, P. LEFF and M. WILLIAMS, Pharmacol Rev. 46 143-156 (1994).
8. C. CASATI, S. MONOMOLI, S. DIONISOTTI, C. ZOCCHI, E. BONIZZONI and E. ONGINI, J. Pharmacol. Exp. Ther. 268 1506-1511 (1994).
9. L.C. MAHAN, L.D. MCVITTIE, E.M. SMYK-RANDALL, H. NAKATA, F.J. MONSMA JR, C.R. GERFEN and D.R. SIBLEY, Mol. Pharmacol. 40 1-7 (1991).
10. S.N. SCHIFFMANN, F. LIBERT, G. VASSART, J.E. DUMONT and J-J. VANDERHAEGHEN, Brain Res. 519 333-337 (1990).
11. F.E. PARKINSON and B..B. FREDHOLM, Mol Neuropharmacol. 1 179-186 (1992).
12. A.G. GILMAN, Ann. Rev. Biochem. 56 615-649 (1987).
13. I. VAN DER PLOEG, F.E PARKINSON and B.B. FREDHOLM, J. Neurochem. 58 1221-1229 (1992).
14. F.E. PARKINSON and B.B. FREDHOLM, J. Neurochem. 58 941-950 (1992).
15. J. FASTBOM, A. PAZOS and J.M. PALACIOS, Neuroscience 22 813-826 (1987).
16. J. FASTBOM and B.B. FREDHOLM, Neuroscience 34 759-769 (1990).
17. F.E. PARKINSON and B.B. FREDHOLM, Naunyn-Schmiedeberg's Arch Pharmacol. 342 85-89 (1990).
18. B. JOHANSSON, V. GEORGIEV, F.E. PARKINSON and B.B. FREDHOLM, Eur. J. Pharmacol., Mol. Pharmacol. Sect. 247 103-110 (1993).
19. B. JONZON, A. BERGQUIST, Y-O. LI and B.B. FREDHOLM, Acta Physiol. Scand. 126 491-498 (1986).
20. H. VAPAATALO, D. ONKEN, P.J. NEUVONEN and E. WESTERMANN, Arzneimittelforschung 25 407-410 (1975).
21. Y. CHERN, H-L. LAI, J.C. FONG and Y. LIANG, Mol. Pharmacol 44 950-958 (1993).
22. B.B. FREDHOLM, B. JONZON and E. LINDGREN, Acta Physiol. Scand 122 55-59 (1984).
23. M.P. ABBRACCHIO, G. FOGLIATTO, A.M. PAOLETTI, G.E. ROVATI and F. CATTABENI, Eur. J. Pharmacol., Mol. Pharmacol. Sect. 258 317-324 (1992).
24. M.S. BRODIE, K. LEE, B.B. FREDHOLM, L. STÅHLE and T.V. DUNWIDDIE, Brain Res. 415323-330 (1987).
25. D.K.J.E. VON LUBITZ, I.A. PAUL, X-D. JI, M. CARTER and K.A. JACOBSON, Eur. J. Pharmacol. 253 95-99 (1994).